Characterizing Patients with Inherited Dilated Cardiomyopathy Requiring Heart Transplantation

被引：0
|
作者：
Elezaby, A. [1 ]
Moscarello, T. [2 ]
Tran, L. [3 ]
Henricksen, E. [2 ]
Parikh, V. N. [1 ]
Haddad, F. [1 ]
Hiesinger, W. [1 ]
Khush, K. [1 ]
Teuteberg, J. [1 ]
Sallam, K. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Stanford Hlth Care, Stanford, CA USA
[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
466
引用
收藏
页码：S232 / S233
页数：2
相关论文
共 50 条
  • [21] Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation
    Tsirka, AE
    Trinkaus, K
    Chen, SC
    Lipshultz, SE
    Towbin, JA
    Colan, SD
    Exil, V
    Strauss, AW
    Canter, CE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (02) : 391 - 397
  • [22] Orthotopic Heart Transplantation in a Patient With Gitelman Syndrome and Dilated Cardiomyopathy
    Solt, Shannon Alexandra
    Hoffman, Timothy M.
    Sharma, Mahesh S.
    Westreich, Katherine D.
    Kihlstrom, Margaret
    Schwartz, Stephanie P.
    WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY, 2020, 11 (04) : 520 - 521
  • [23] Transplantation of allogenic cells in the therapy of patients with dilated cardiomyopathy
    Kirillov, A. M.
    Fatkhudinov, T. Kh.
    Dyachkov, A. V.
    Koroteev, A. V.
    Goldshtein, D. V.
    Bochkov, N. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (04) : 635 - 639
  • [24] Transplantation of allogenic cells in the therapy of patients with dilated cardiomyopathy
    A. M. Kirillov
    T. Kh. Fatkhudinov
    A. V. Dyachkov
    A. V. Koroteev
    D. V. Goldshtein
    N. P. Bochkov
    Bulletin of Experimental Biology and Medicine, 2007, 144 : 635 - 639
  • [25] DOMINANTLY INHERITED DILATED CARDIOMYOPATHY IN A SOMERSET FAMILY
    SKIRTON, H
    LUNT, P
    JAMES, M
    WALKER, S
    JOURNAL OF MEDICAL GENETICS, 1995, 32 (02) : 149 - 149
  • [26] Pathogenesis of inherited forms of dilated cardiomyopathy.
    Graham, RM
    Owens, WA
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (23): : 1759 - 1762
  • [27] Predictive factors for requiring heart transplantation in patients with hypertrophic cardiomyopathy: data from a referral center
    Brufau-Cochs, M.
    Ramos-Jovani, M.
    Lopez Sainz, A.
    Farrero, M.
    Castel, M. A.
    Sole-Gonzalez, E.
    Quintana, E.
    Sandoval, E.
    Pereda, D.
    Rodriguez Arias, J. J.
    Fernandez Valledor, A.
    Castella, M.
    Perez-Villa, F.
    Sitges, M.
    Garcia-Alvarez, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1779 - 1779
  • [28] Growth factor therapy for patients with end-stage dilated cardiomyopathy on heart transplantation list
    Komamura, K
    Hanatani, A
    Doi, K
    Nakatani, T
    Kitamura, S
    Miyatake, K
    Kitakaze, M
    CIRCULATION, 2005, 112 (17) : U517 - U517
  • [29] Usefulness of intracoronary therapy with progenitor cells in patients with dilated cardiomyopathy: Bridge or alternative to heart transplantation?
    Rivas, J.
    Menendez, J. J.
    Arrieta, R.
    Alves, J.
    Romero, M. P.
    Garcia-Guereta, L.
    Alvarez-Doforno, R.
    Parron, M.
    Gonzalez, A.
    Ruza, F.
    Gutierrez-Larraya, F.
    ANALES DE PEDIATRIA, 2011, 74 (04): : 218 - 225
  • [30] Clinical Variables Associated With the Presence of Inflammatory Infiltrates in Patients With Dilated Cardiomyopathy Undergoing Heart Transplantation
    Aguero, J.
    Navarro, J.
    Medina, M. C.
    Almenar, L.
    Chirivella, M.
    Martinez-Dolz, L.
    Moro, J. A.
    Sanchez-Lazaro, I.
    Ortiz, V.
    Raso, R.
    Salvador, A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 3017 - 3019
12345